News for Astrazeneca PLC
Dec 15 · 10:42:00 AM
AstraZeneca and the University of Virginia in Charlottesville Tuesday announced that they have entered into a strategic research collaboration to enhance development of new treatments primarily for coronary artery disease (CAD) with a secondary focus on peripheral vascular disease (PAD).
http://www.prnewswire.com/news-releases/astrazeneca-and-the-university-of-virginia-sign-strategic-research-collaboration-to-develop-novel-treatments-for-cardiovascular-disease-79304982.html
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Oct 29 · 11:33:00 AM · Source: Company News Release
AstraZeneca said its net income increased 23 percent to $2.12 billion from $1.73 billion a year earlier. Earnings excluding restructuring and other one-time costs gained to $1.68 a share from $1.32, beating analysts' forecasts. Third-quarter sales gained 5.4 percent to $8.2 billion.
Earnings rose on Swine Flu vaccine.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Advertisement